| Primary |
| Blood Testosterone Decreased |
30.1% |
| Drug Use For Unknown Indication |
16.5% |
| Product Used For Unknown Indication |
15.9% |
| Hormone Replacement Therapy |
10.8% |
| Hypogonadism Male |
3.4% |
| Hypertension |
2.8% |
| Hypogonadism |
2.8% |
| Androgen Deficiency |
1.7% |
| Decreased Appetite |
1.7% |
| Drug Abuse |
1.7% |
| Metastatic Renal Cell Carcinoma |
1.7% |
| Supplementation Therapy |
1.7% |
| Blood Cholesterol Increased |
1.1% |
| Blood Testosterone |
1.1% |
| Depression |
1.1% |
| Diabetes Mellitus |
1.1% |
| Fatigue |
1.1% |
| Glaucoma |
1.1% |
| Organic Erectile Dysfunction |
1.1% |
| Pain In Jaw |
1.1% |
|
| Product Quality Issue |
9.3% |
| Application Site Erythema |
7.0% |
| Endometrial Cancer Stage I |
7.0% |
| Hallucination |
7.0% |
| Pharmaceutical Product Complaint |
7.0% |
| Pulmonary Embolism |
7.0% |
| Skin Reaction |
7.0% |
| Application Site Rash |
4.7% |
| Pain |
4.7% |
| Rash |
4.7% |
| Rash Erythematous |
4.7% |
| Testicular Pain |
4.7% |
| Therapeutic Response Unexpected |
4.7% |
| Thinking Abnormal |
4.7% |
| Vomiting |
4.7% |
| Application Site Burn |
2.3% |
| Application Site Dermatitis |
2.3% |
| Application Site Exfoliation |
2.3% |
| Application Site Irritation |
2.3% |
| Application Site Pain |
2.3% |
|
| Secondary |
| Blood Testosterone Decreased |
25.1% |
| Product Used For Unknown Indication |
11.3% |
| Hormone Replacement Therapy |
8.4% |
| Drug Use For Unknown Indication |
6.7% |
| Hypertension |
6.3% |
| Hypogonadism |
4.6% |
| Accidental Exposure |
4.2% |
| Depression |
4.2% |
| Leukocytoclastic Vasculitis |
4.2% |
| Seasonal Allergy |
4.2% |
| Rheumatoid Arthritis |
3.3% |
| Arthritis |
2.9% |
| Blood Cholesterol Increased |
2.1% |
| Food Allergy |
2.1% |
| Rhinitis Allergic |
2.1% |
| Androgen Replacement Therapy |
1.7% |
| Glaucoma |
1.7% |
| Hypothyroidism |
1.7% |
| Ill-defined Disorder |
1.7% |
| Nutritional Support |
1.7% |
|
| Precocious Puberty |
18.4% |
| Therapeutic Response Unexpected |
8.2% |
| Hallucination |
6.1% |
| Pain |
6.1% |
| Unresponsive To Stimuli |
6.1% |
| Drug Interaction |
4.1% |
| Flatulence |
4.1% |
| Haematocrit Increased |
4.1% |
| Idiopathic Thrombocytopenic Purpura |
4.1% |
| Loss Of Libido |
4.1% |
| Pituitary Tumour |
4.1% |
| Screaming |
4.1% |
| Throat Irritation |
4.1% |
| Urine Flow Decreased |
4.1% |
| Visual Disturbance |
4.1% |
| Weight Decreased |
4.1% |
| X-ray Abnormal |
4.1% |
| Ankle Fracture |
2.0% |
| Blepharitis |
2.0% |
| Breast Cancer |
2.0% |
|
| Concomitant |
| Product Used For Unknown Indication |
40.6% |
| Hypertension |
8.0% |
| Drug Use For Unknown Indication |
5.3% |
| Osteoporosis |
5.3% |
| Pain |
4.2% |
| Hiv Infection |
3.8% |
| Rheumatoid Arthritis |
3.6% |
| Glioblastoma Multiforme |
3.3% |
| Depression |
2.9% |
| Gastrooesophageal Reflux Disease |
2.9% |
| Hypogonadism |
2.9% |
| Ill-defined Disorder |
2.7% |
| Constipation |
2.2% |
| Hormone Replacement Therapy |
2.2% |
| Mantle Cell Lymphoma |
2.2% |
| Blood Testosterone Decreased |
1.8% |
| Hypothyroidism |
1.6% |
| Malignant Glioma |
1.6% |
| Multiple Myeloma |
1.6% |
| Back Pain |
1.4% |
|
| Electrocardiogram Qt Prolonged |
9.9% |
| Urinary Tract Infection |
9.9% |
| Arthritis |
8.5% |
| Death |
8.5% |
| Electrocardiogram Qt Corrected Interval Prolonged |
7.0% |
| Pneumonia |
5.6% |
| Wheezing |
5.6% |
| Depression |
4.2% |
| Dyspnoea |
4.2% |
| Flushing |
4.2% |
| Pulmonary Congestion |
4.2% |
| Surgery |
4.2% |
| Syncope |
4.2% |
| Balance Disorder |
2.8% |
| Cardiac Failure Congestive |
2.8% |
| Dehydration |
2.8% |
| Diabetes Mellitus Non-insulin-dependent |
2.8% |
| Drug Ineffective |
2.8% |
| Fatigue |
2.8% |
| Gait Disturbance |
2.8% |
|
| Interacting |
| Blood Cholesterol Increased |
25.0% |
| Blood Testosterone Decreased |
25.0% |
| Diabetes Mellitus |
25.0% |
| Muscle Relaxant Therapy |
25.0% |
|
|
